Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

<< Previous

Bullboard Posts

Next >>

Post by bealerton Jun 23, 2022 3:34pm

225 Views

Post# 34778252

To Navajojoe

Why don't you tweet that lady in your link and tell her about Sirona and their product. Maybe that will give us huge mileage.

I personally don't do any social media or I would figure out how to contact her.

Thanks and good luck investing, everyone.

That buy recommendation looks interesting.

Just a matter of time till it rockets.

BeAlert

<< Previous

Bullboard Posts

Next >>

Sony’s Alpha 1 II: A new professional photography standard?